JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harriman, J. F.
Right arrow Articles by Schnellmann, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harriman, J. F.
Right arrow Articles by Schnellmann, R. G.

Vol. 294, Issue 3, 1083-1087, September 2000

Efficacy of Novel Calpain Inhibitors in Preventing Renal Cell Death1

Jay F. Harriman, Shayla Waters-Williams2 , Der-Lun Chu, James C. Powers and Rick G. Schnellmann

Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (J.F.H., S.W.-W., R.G.S.); and School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia (D.-L.C., J.C.P.)

Inhibitors of calpains, calcium-activated neutral proteases, protect against cell death produced by anoxia and a variety of toxicants both in vitro and in vivo. The problems with known calpain inhibitors are a lack of specificity, low membrane permeability, and/or low potency. The goal of this study was to determine the effects of seven novel dipeptide and tripeptide calpain inhibitors on calpain activity and antimycin A-induced cell death in rabbit renal proximal tubule (RPT) suspensions. We chose the compounds based on their inhibitory constants for µ- versus m-calpain, specificity of the inhibitors for calpain, and membrane permeability. Only three of the compounds inhibited calpain in RPT and were cytoprotective (Z-Leu-Phe-COOH, Z-Leu-Abu-CONH-CH2-CH(OH)-Ph, and Z-Leu-Phe-CONH-Et). Interestingly, Z-Leu-Phe-COOEt, Z-Leu-Abu-CONH-CH2-CH(OH)-C6F5, and Z-Leu-Abu-CONH-CH2-2-quinolinyl were greater than 60% cytoprotective but did not inhibit calpain in RPT. Z-Leu-Abu-CONH(CH2)3-morpholine was neither cytoprotective nor inhibited calpain. Although these results suggest that six of the seven peptide calpain inhibitors are cell permeable, only three of them inhibited calpain activity in RPT and were cytoprotective. Their ability to inhibit calpain or produce cytoprotection did not correlate with their ability to selectively inhibit purified µ- or m-calpain. Thus it remains to be determined whether they inhibit µ-calpain, m-calpain, or both in RPT. These results also suggest that inhibition of other protease(s) in addition to calpains may be responsible for the cytoprotective actions of some compounds.


1 This publication was made possible by Grant ES-09129 from the National Institute of Environmental Health Sciences, National Institutes of Health. J.F.H. was supported by an American Heart Association Heartland Affiliate Predoctoral Fellowship and University of Arkansas for Medical Sciences Graduate Student Research Funds.

2 Current address: Center for Toxicology and Environmental Health, 4301 W. Markham St., Slot 767, Little Rock, AR 72205-7199.


0022-3565/00/2943-1083$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
M. Peyrou, P. E. Hanna, and A. E. Cribb
Cisplatin, Gentamicin, and p-Aminophenol Induce Markers of Endoplasmic Reticulum Stress in the Rat Kidneys
Toxicol. Sci., September 1, 2007; 99(1): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. J. Padanilam
Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F608 - F627.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Liu and R. G. Schnellmann
Calpain Mediates Progressive Plasma Membrane Permeability and Proteolysis of Cytoskeleton-Associated Paxillin, Talin, and Vinculin during Renal Cell Death
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 63 - 70.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Liu, J. F. Harriman, and R. G. Schnellmann
Cytoprotective Properties of Novel Nonpeptide Calpain Inhibitors in Renal Cells
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 88 - 94.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.